Hepatitis B virus elimination status and strategies in circumpolar countries, 2020

Hepatitis B virus (HBV) infection remains a global health threat. The World Health Organization (WHO) established a goal to eliminate HBV infection as a public health threat by 2030, and defined targets for key interventions to achieve that goal. We evaluated HBV burden and relevant national recomme...

Full description

Saved in:
Bibliographic Details
Published in:International journal of circumpolar health 2021-01, Vol.80 (1), p.1986975-1986975
Main Authors: Haering, Celia, McMahon, Brian, Harris, Aaron, Weis, Nina, Lundberg Ederth, Josefine, Axelsson, Maria, Olafsson, Sigurdur, Osiowy, Carla, Tomas, Kristina, Bollerup, Signe, Liitsola, Kirsi, Archibald, Chris, Blystad, Hans, Bruce, Michael, Nolen, Leisha
Format: Article
Language:English
Subjects:
Circumpolar Viral Hepatitis Working Group
elimination
Hepatitis B
Hepatitis B infection
Immunization
Original
policy survey
Public health
public health policy
vaccination recommendation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatitis B virus (HBV) infection remains a global health threat. The World Health Organization (WHO) established a goal to eliminate HBV infection as a public health threat by 2030, and defined targets for key interventions to achieve that goal. We evaluated HBV burden and relevant national recommendations for progress towards WHO targets in circumpolar countries. Viral hepatitis experts of circumpolar countries were surveyed regarding their country's burden of HBV, achievement of WHO targets and national public health authority recommendations for HBV prevention and control. Eight of nine circumpolar countries responded. All countries continue to see new HBV infections. Data about HBV prevalence and progress in reaching WHO 2030 elimination targets are lacking. No country was able to report data for all seven WHO target measures. All countries have recommendations targeting the prevention of mother-to-child transmission. Only the USA and Greenland recommend universal birth dose vaccination. Four countries have recommendations to screen persons at high risk for HBV. Existing recommendations largely address prevention; however, recommendations for universal birth dose vaccination have not been widely introduced. Opportunities remain for the development of trackable targets and national elimination planning to screen and treat for HBV to reduce incidence and mortality.
ISSN:2242-3982
1239-9736
2242-3982
DOI:10.1080/22423982.2021.1986975